Search Results 1561-1570 of 19436 for hemoglobin
Hemoglobin > 8 g/dL;; Resolved acute effects of any prior therapy to baseline severity or Common Terminology Criteria for Adverse Events (CTCAE) Grade < 1 ...
* Hemoglobin levels \< 8.0 g/dL (\< 5 mmol/L), or \< 7.0 g/dL (\< 4.3 mmol/L) if related to participant's SLE such as in active hemolytic anaemia * Platelet ...
Adequate hematological function (neutrophils >1 × 109/L, platelet count >100 × 109/L, hemoglobin >9 g/dL) with no prior transfusions within 2 weeks.
Hemoglobin < 9.0 mg/dl, INR > 1.6 before warfarin was started, or platelets < 100,000/ml. Moderate renal impairment in diabetic patients (estimated GFR < 60 ...
Hemoglobin < 9 g/dL in males and < 8 g/dL in females;; Neutrophils < 1.0 × 10^9/L;; Platelets < 75 × 10^9/L;; Creatinine clearance < 50 mL/min on screening ...
Patients must have adequate organ and marrow function as defined by the following laboratory values obtained ≤14 days prior to registration: Hemoglobin > 9.0 g ...
In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...
Hemoglobin > 8 g/dL;; Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) < 20 times the upper limit of the institutional normal ranges. Women ...
* Hemoglobin ≥ 9.0 g/dL * Serum creatinine ≤ 1.5 x upper limit of normal (ULN) * Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.